Drug intelligence / Profile preview

Mirtoselect Bilberry Extract

Development stage
Unknown
Lead developer
Indena
Modality
Small Molecules
Administration
Oral
01

Overview

Mirtoselect Bilberry Extract is a **standardized extract of bilberry (Vaccinium myrtillus L.) fruit** clinically studied and characterized by a content of ≥36% anthocyanins (by HPLC), with ≤1% anthocyanidins. It is renowned for evidence-based benefits in vascular and retinal (eye) health, including improving contrast sensitivity and tear secretion, with additional indications for metabolic and cardiovascular health. Its mechanisms are attributed mainly to its anthocyanin profile, conferring potent antioxidant and microvascular-stabilizing effects. Clinical studies show improvement in antioxidant potential and support for eye conditions, especially dry eye, as well as possible benefits in memory and blood sugar support[1][3].

Brand names
Mirtoselect
Other names
Vaccinium myrtillus standardized extractstandardized bilberry extract
02

Targets

GABRR (GABA-A receptor subunit rho)ABAT (4-aminobutyrate aminotransferase)AcetylcholinesteraseMAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on Mirtoselect Bilberry Extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mirtoselect Bilberry Extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call